Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Warren A Chow

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
F1000Research|December 7, 2018
Chondrosarcoma: biology, genetics, and epigeneticsWarren A Chow
Journal of Oncology Practice|March 11, 2016
Bones: The Adult Sarcoma DramaWarren A Chow
Current Opinion in Oncology|June 5, 2007
Update on chondrosarcomasWarren A Chow
Current Treatment Options in Oncology|February 22, 2022
Systemic Therapy for ChondrosarcomaAdam Rock, Sana Ali, Warren A Chow
Expert Review of Anticancer Therapy|August 26, 2010
Novel targeted therapies in the treatment of soft-tissue sarcomasJoseph Chao, Warren A Chow, George Somlo
The FEBS Journal|May 1, 2012
Nelfinavir inhibits regulated intramembrane proteolysis of sterol regulatory element binding protein-1 and activating transcription factor 6 in castration-resistant prostate cancerMin Guan, Kristen Fousek, Warren A Chow
The Lancet. Oncology|December 30, 2008
Anti-HIV drugs for cancer therapeutics: back to the future?Warren A Chow, Chunling Jiang, Min Guan
Anti-Cancer Drugs|August 31, 2006
Nelfinavir induces liposarcoma apoptosis and cell cycle arrest by upregulating sterol regulatory element binding protein-1Warren A Chow, Song Guo, Frances Valdes-Albini
Cancers|June 12, 2026
The Evolving Landscape of Systemic Therapy for LiposarcomaHee Kyung Kim, Akshat Sarkari, Warren A Chow
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 19, 2013
Complete pathologic response in soft tissue sarcoma lung metastases with pazopanibZeynep Eroglu, Jae Kim, Sharon Wilczynski, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
F1000Research|December 7, 2018
Chondrosarcoma: biology, genetics, and epigeneticsWarren A Chow
Journal of Oncology Practice|March 11, 2016
Bones: The Adult Sarcoma DramaWarren A Chow
Current Opinion in Oncology|June 5, 2007
Update on chondrosarcomasWarren A Chow
Current Treatment Options in Oncology|February 22, 2022
Systemic Therapy for ChondrosarcomaAdam Rock, Sana Ali, Warren A Chow
Expert Review of Anticancer Therapy|August 26, 2010
Novel targeted therapies in the treatment of soft-tissue sarcomasJoseph Chao, Warren A Chow, George Somlo
The FEBS Journal|May 1, 2012
Nelfinavir inhibits regulated intramembrane proteolysis of sterol regulatory element binding protein-1 and activating transcription factor 6 in castration-resistant prostate cancerMin Guan, Kristen Fousek, Warren A Chow
The Lancet. Oncology|December 30, 2008
Anti-HIV drugs for cancer therapeutics: back to the future?Warren A Chow, Chunling Jiang, Min Guan
Anti-Cancer Drugs|August 31, 2006
Nelfinavir induces liposarcoma apoptosis and cell cycle arrest by upregulating sterol regulatory element binding protein-1Warren A Chow, Song Guo, Frances Valdes-Albini
Cancers|June 12, 2026
The Evolving Landscape of Systemic Therapy for LiposarcomaHee Kyung Kim, Akshat Sarkari, Warren A Chow
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 19, 2013
Complete pathologic response in soft tissue sarcoma lung metastases with pazopanibZeynep Eroglu, Jae Kim, Sharon Wilczynski, et al.
Pageof 4